Cyclophosphamide/Epirubicin/Prednisone/Rituximab/Vincristine Regimen

Preferred Label : Cyclophosphamide/Epirubicin/Prednisone/Rituximab/Vincristine Regimen;

NCIt synonyms : Rituximab-Cyclophosphamide-Epirubicin-Oncovin-Prednisone Regimen; Cyclophosphamide/Epirubicin/Prednisone/Rituximab/Vincristine; Cyclophosphamide-Epirubicin-Prednisone-Rituximab-Vincristine; Cyclophosphamide-Epirubicin-Prednisone-Rituximab-Vincristine Regimen; R-CEOP90 Regimen;

NCIt related terms : R-CEOP90 (rituximab-blit); R-CEOP90 (rituximab-pvvr); R-CEOP90 (rituximab-rixi); R-CEOP90 (rituximab-rite); R-CEOP90 (rituximab-rixa); R-CEOP90 (rituximab-abbs); R-CEOP90; R-CEOP90 (rituximab-arrx);

NCIt definition : A regimen consisting of rituximab, cyclophosphamide, epirubicin, vincristine and prednisone that can be used to treat diffuse large B-cell lymphoma (DLBCL).;

NCI Metathesaurus CUI : CL1664732;

Codes from synonyms : 127926; 128554; 128711; 127769; 70112; 128397; 128240; 128083;

Détails

Origin ID

C181649;

UMLS CUI

C5557197;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Epirubicin Hydrochloride [NCIt concept]
- Prednisone [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine Sulfate [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients